Gout - Complete Guide to Gout!
Answers to your Gout Questions
(Reuters) – Patients with the most serious form of childhood arthritis can get substantial symptom relief from a Novartis drug, researchers said on Friday, raising hopes for a product that had a recent setback in its application to treat gout.
Visit site:
Novartis drug helps in serious childhood arthritis
The US Food and Drug Administration panel voted 11-1 against recommending a Novartis drug for the treatment of gout.
View article:
FDA Votes Against Arthritis Drug
NEW YORK (MarketWatch) — The Food and Drug Administration advisory committee voted 11-1 against approving the Novartis AG gout drug Ilaris, according to a report published Wednesday. The Wall Street Journal said the FDA was concerned about safety issues, because patients receiving just one injection of the gout-drug had a higher rate of serious infections compared with steroid injections in …
Read More:
FDA votes against Novartis gout drug: WSJ
FDA Panel Votes Against Recommending Novartis Gout Treatment
More:
FDA Panel Votes Against Recommending Novartis Gout Treatment
ZURICH : Novartis AG’s prospective gout treatment gives patients better pain relief and significantly cuts the risk of new attacks, two late stage studies showed, giving the drugmaker’s pipeline another boost.
See the original article here:
Novartis drug gives pain relief in gouty arthritis
